StockData
Northwest Biotherapeutics Inc logo

Northwest Biotherapeutics Inc (NWBO) stock

NWBOOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 1/30
$0.16−0.00 (-0.88%)

Close on Oct 19, 2026Market cap $254.79MP/E –Yield –

Northwest Biotherapeutics market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Northwest Biotherapeutics's market cap was $258.96M on Oct 19, 2026, against $361.05M a year earlier. Over the last 5 years it ranged from $746 to $1.01B, with a median of $441.67M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Oct 19, 2026$258.96M-25.4%
2025Dec 31, 2025$347.31M-1.7%
2024Dec 31, 2024$353.41M-55.9%
2023Dec 29, 2023$801.57M+97752339.0%
2022Dec 30, 2022$820-100.0%
2021Dec 31, 2021$624.33M-47.7%
2020Dec 31, 2020$1.19B+874.7%
2019Dec 31, 2019$122.39M+14.3%
2018Dec 31, 2018$107.12M+44.1%
2017Dec 29, 2017$74.32M+75.8%
2016Dec 30, 2016$42.27M-83.1%
2015Dec 31, 2015$250.14M-24.9%
2014Dec 31, 2014$332.87M+141.0%
2013Dec 31, 2013$138.13M+428273.0%
2012Dec 31, 2012$32.25K-7.8%
2011Dec 30, 2011$34.96K–

More Northwest Biotherapeutics figures

See a number that looks wrong?